New Science Ventures leads Novadip’s €10.4 million convertible financing round
New Science Ventures led Novadip’s € 10.4 million convertible financing round disclosed Sept. 21, 2026. Novadip is a late-stage regenerative medicine biotech developing cell-based therapies for bone repair. Proceeds fund completion of a pivotal Phase 3 trial for NVD003 in congenital pseudarthrosis of the tibia. Round l